I am concerned also in terms of what is theoretical capacity and what is actual capacity. I think what I've heard is that it's pretty difficult for any commercial enterprise to justify stopping its regular lines of vaccine production when asked to do so in order to provide a short run of enough for a clinical trial.
So I come back to the concerns that are swirling around the methodology of the Gates report. I would like to know more about that, but I'd also like to know more about what happens to the money from the Gates Foundation and to the money that was to be used to build this facility, and where it will be redirected or reapplied in terms of the commitment this government has had to fight against this pandemic. What happens to the money the Gates Foundation had previously allocated to this facility? Is there a consultation among the experts, such as those at this table, in terms of where the Canadian government money would go if this project doesn't go forward, in that we have had a commitment it will go in a fight against AIDS?